Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMID 7046755)

Published in Biochem Pharmacol on April 01, 1982

Authors

J C Henquin, H P Meissner

Articles citing this

Calcium and delayed potassium currents in mouse pancreatic beta-cells under voltage-clamp conditions. J Physiol (1986) 3.46

Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells. J Clin Invest (1992) 2.06

Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Br J Pharmacol (1988) 2.05

Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells. J Clin Invest (1993) 1.59

Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol (1989) 1.52

Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1990) 1.45

Regulation of calcium in pancreatic α- and β-cells in health and disease. Cell Calcium (2011) 1.29

The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol (1990) 1.26

Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca(2+) channels from secretory granules. Cell Metab (2009) 1.26

A novel approach to in situ characterization of pancreatic beta-cells. Pflugers Arch (2003) 1.23

Influence of cell number on the characteristics and synchrony of Ca2+ oscillations in clusters of mouse pancreatic islet cells. J Physiol (1999) 1.22

Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels. Br J Pharmacol (1990) 1.20

Effects of putative activators of K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1989) 1.17

Stimulation of the KATP channel by ADP and diazoxide requires nucleotide hydrolysis in mouse pancreatic beta-cells. J Physiol (1993) 1.13

High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. Br Med J (Clin Res Ed) (1987) 1.11

Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells. Br J Pharmacol (1992) 1.11

Potassium channels and airway function: new therapeutic prospects. Thorax (1990) 1.10

Progression of diet-induced diabetes in C57BL6J mice involves functional dissociation of Ca2(+) channels from secretory vesicles. Diabetes (2010) 1.06

The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells. Br J Pharmacol (1990) 1.02

Two sites of glucose control of insulin release with distinct dependence on the energy state in pancreatic B-cells. Biochem J (1994) 1.01

Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br J Pharmacol (1996) 0.95

Distinct mechanisms for two amplification systems of insulin release. Biochem J (1987) 0.95

Multiplicity of effectors of the cardioprotective agent, diazoxide. Pharmacol Ther (2013) 0.95

Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells. Br J Pharmacol (1988) 0.93

Sulphonylureas reduce the slowly inactivating D-type outward current in rat hippocampal neurons. J Physiol (1993) 0.90

Nucleotide-dependent activation of KATP channels by diazoxide in CRI-G1 insulin-secreting cells. Br J Pharmacol (1992) 0.87

Tissue kallikrein permits early renal adaptation to potassium load. Proc Natl Acad Sci U S A (2010) 0.85

Effects of potassium channel openers and their antagonists on rat locus coeruleus neurones. Br J Pharmacol (1993) 0.82

Relaxation and decrease in [Ca2+]i by hydrochlorothiazide in guinea-pig isolated mesenteric arteries. Br J Pharmacol (1995) 0.82

Inhibition by hydrochlorothiazide of insulin release and calcium influx in mouse pancreatic beta-cells. Br J Pharmacol (1993) 0.82

KATP Channels in the Cardiovascular System. Physiol Rev (2016) 0.82

Pentoxifylline decreases glycemia levels and TNF-alpha, iNOS and COX-2 expressions in diabetic rat pancreas. Springerplus (2014) 0.80

Mechanisms of the stimulation of insulin release by oxytocin in normal mouse islets. Biochem J (1991) 0.79

Relationships between the Na(+)/K(+) pump and ATP and ADP content in mouse pancreatic islets: effects of meglitinide and glibenclamide. Br J Pharmacol (2000) 0.79

Adamantane derivatives: a new class of insulin secretagogues. Br J Pharmacol (1987) 0.79

Cibenzoline inhibits diazoxide- and 2,4-dinitrophenol-activated ATP-sensitive K+ channels in guinea-pig ventricular cells. Br J Pharmacol (1993) 0.78

Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca(2+) response. Br J Pharmacol (2001) 0.78

Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats. Br J Pharmacol (1999) 0.78

Comparison of the effects of putative activators of K+ channels on pancreatic B-cell function. Pflugers Arch (1989) 0.75

Articles by these authors

Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab (2008) 3.96

Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev (2001) 2.92

Membrane potential of beta-cells in pancreatic islets. Pflugers Arch (1974) 2.74

Cellular composition of the human diabetic pancreas. Diabetologia (1983) 2.71

Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic B-cells. Experientia (1984) 2.43

Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest (1997) 2.21

Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells. J Clin Invest (1992) 2.06

Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. J Biol Chem (1993) 1.95

D-glucose inhibits potassium efflux from pancreatic islet cells. Nature (1978) 1.86

Electrophysiological evidence for coupling between beta cells of pancreatic islets. Nature (1976) 1.86

Culture duration and conditions affect the oscillations of cytoplasmic calcium concentration induced by glucose in mouse pancreatic islets. Diabetologia (1994) 1.66

Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J Biol Chem (1992) 1.64

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 1.63

Interplay between cytoplasmic Ca2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Biochem J (1998) 1.59

Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells. J Clin Invest (1993) 1.59

The kinetics of electrical activity of beta cells in response to a "square wave" stimulation with glucose or glibenclamide. Horm Metab Res (1976) 1.55

Electrical characteristics of the beta-cells in pancreatic islets. J Physiol (Paris) (1976) 1.53

Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1990) 1.45

Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes (1994) 1.44

Tight links between adenine and guanine nucleotide pools in mouse pancreatic islets: a study with mycophenolic acid. Biochem J (1997) 1.43

The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets. J Biol Chem (1998) 1.39

Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia (1980) 1.34

Uptake and release of Ca2+ by the endoplasmic reticulum contribute to the oscillations of the cytosolic Ca2+ concentration triggered by Ca2+ influx in the electrically excitable pancreatic B-cell. J Biol Chem (1999) 1.33

Pronase effect on pancreatic beta cell secretion and morphology. Science (1973) 1.31

The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology (1984) 1.23

Influence of cell number on the characteristics and synchrony of Ca2+ oscillations in clusters of mouse pancreatic islet cells. J Physiol (1999) 1.22

Possible links between glucose-induced changes in the energy state of pancreatic B cells and insulin release. Unmasking by decreasing a stable pool of adenine nucleotides in mouse islets. J Clin Invest (1995) 1.21

Concentration dependence and time course of the effects of glucose on adenine and guanine nucleotides in mouse pancreatic islets. J Biol Chem (1996) 1.20

Effects of amino acids on membrane potential and 86Rb+ fluxes in pancreatic beta-cells. Am J Physiol (1981) 1.19

Stable and diffusible pools of nucleotides in pancreatic islet cells. Endocrinology (1996) 1.17

Tetraethylammonium potentiation of insulin release and inhibition of rubidium efflux in pancreatic islets. Biochem Biophys Res Commun (1977) 1.17

Cyclic variations of glucose-induced electrical activity in pancreatic B cells. Pflugers Arch (1982) 1.17

Cobalt inhibition of insulin secretion and calcium uptake by isolated rat islets. Am J Physiol (1975) 1.17

Effects of putative activators of K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1989) 1.17

Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli. Diabetes (1982) 1.15

High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells. J Biol Chem (2001) 1.11

Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells. Br J Pharmacol (1992) 1.11

High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. Br Med J (Clin Res Ed) (1987) 1.11

The ionic, electrical, and secretory effects of protein kinase C activation in mouse pancreatic B-cells: studies with a phorbol ester. Endocrinology (1987) 1.10

Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response. Diabetes (2001) 1.10

Emptying of intracellular Ca2+ stores stimulates Ca2+ entry in mouse pancreatic beta-cells by both direct and indirect mechanisms. J Physiol (1997) 1.10

Quinine-induced modifications of insulin release and glucose metabolism by isolated pancreatic islets. FEBS Lett (1975) 1.10

Metabolic control of potassium permeability in pancreatic islet cells. Biochem J (1980) 1.07

Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications. Diabetologia (1987) 1.07

The influence of gamma-aminobutyric acid on hormone release by the mouse and rat endocrine pancreas. Endocrinology (1991) 1.06

Potassium dependence of the membrane potential of pancreatic B-cells. FEBS Lett (1978) 1.05

Glucagon immunoassay using polyethylene glycol to precipitate antibody-bound hormone. Diabetologia (1974) 1.04

Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia (1981) 1.04

Disorganization of cytoplasmic Ca(2+) oscillations and pulsatile insulin secretion in islets from ob/ obmice. Diabetologia (2002) 1.03

Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue. FEBS Lett (1995) 1.03

Distinct effects of glucose on the synchronous oscillations of insulin release and cytoplasmic Ca2+ concentration measured simultaneously in single mouse islets. Endocrinology (1995) 1.03

Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia (1993) 1.02

Quinine and the stimulus-secretion coupling in pancreatic beta-cells: glucose-like effects on potassium permeability and insulin release. Endocrinology (1982) 1.02

The islet in type 2 diabetes: back to center stage. Diabetes (2001) 1.01

Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2+ in mouse pancreatic beta-cells. Diabetes (1998) 1.01

Two sites of glucose control of insulin release with distinct dependence on the energy state in pancreatic B-cells. Biochem J (1994) 1.01

Insulin release, cGMP, cAMP, and membrane potential in acetylcholine-stimulated islets. Am J Physiol (1978) 1.01

Oscillations of insulin secretion can be triggered by imposed oscillations of cytoplasmic Ca2+ or metabolism in normal mouse islets. Diabetes (1999) 1.00

The K+-ATP channel-independent pathway of regulation of insulin secretion by glucose: in search of the underlying mechanism. Diabetes (1998) 0.99

Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia (1985) 0.98

Effects of trifluoperazine and pimozide on stimulus-secretion coupling in pancreatic B-cells. Suggestion for a role of calmodulin? Biochem J (1981) 0.98

The role of protein kinase-C in signal transduction through vasopressin and acetylcholine receptors in pancreatic B-cells from normal mouse. Endocrinology (1994) 0.97

A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids. Biochem J (1982) 0.97

Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype. Diabetes (1999) 0.96

Forskolin, an activator of adenylate cyclase, increases CA2+-dependent electrical activity induced by glucose in mouse pancreatic B cells. Endocrinology (1983) 0.96

Glucose-induced changes of the membrane potential of pancreatic B-cells: their significance for the regulation of insulin release. Adv Exp Med Biol (1979) 0.95

Bicarbonate modulation of glucose-9nduced biphasic insulin release by rat islets. Am J Physiol (1976) 0.95

Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia (2003) 0.95

Dibutyryl cyclic AMP triggers Ca2+ influx and Ca2+-dependent electrical activity in pancreatic B cells. Biochem Biophys Res Commun (1983) 0.95

Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med (1999) 0.94

The potassium permeability of pancreatic islet cells: mechanisms of control and influence on insulin release. Horm Metab Res Suppl (1980) 0.94

Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse islets. Biochem J (1988) 0.94

9-Aminoacridine- and tetraethylammonium-induced reduction of the potassium permeability in pancreatic B-cells. Effects on insulin release and electrical properties. Biochim Biophys Acta (1979) 0.94

Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am J Physiol Endocrinol Metab (2004) 0.93

Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells. Br J Pharmacol (1988) 0.93

Distinct effects of acetylcholine and glucose on 45calcium and 86rubidium efflux from mouse pancreatic islets. FEBS Lett (1984) 0.93

Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology (1989) 0.92

Mechanisms of the stimulation of insulin release by arginine-vasopressin in normal mouse islets. J Biol Chem (1990) 0.92

Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1991) 0.92

Electrogenic sodium pump in beta-cells of islets of Langerhans. J Physiol (1975) 0.92

The interplay between cyclic AMP and ions in the stimulus-secretion coupling in pancreatic B-cells. Arch Int Physiol Biochim (1985) 0.91

Modulation of the effect of acetylcholine on insulin release by the membrane potential of B cells. Endocrinology (1987) 0.90

Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells. Endocrinology (1999) 0.90

Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia (1996) 0.90

The role of metabolism, cytoplasmic Ca2+, and pH-regulating exchangers in glucose-induced rise of cytoplasmic pH in normal mouse pancreatic islets. J Biol Chem (1995) 0.90

Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels. Br J Pharmacol (2010) 0.90

High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFkappaB. Diabetologia (2005) 0.89

Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells. Eur J Pharmacol (1996) 0.89

Relative importance of extracellular and intracellular calcium for the two phases of glucose-stimulated insulin release: studies with theophylline. Endocrinology (1978) 0.89

Cationic environment and dynamics of insulin secretion. III. Effect of the absence of potassium. Diabetologia (1974) 0.89

G protein-dependent inhibition of L-type Ca2+ currents by acetylcholine in mouse pancreatic B-cells. J Physiol (1997) 0.89